-
Symbol
-
RNTX on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.001 par value
-
Latest Disclosed Ownership
-
3.68M shares
-
Security Ownership
-
6.2%
BIOS EQUITY PARTNERS III, LP ownership in Rein Therapeutics, Inc. Common Stock, $0.001 par value (RNTX)
2025-08-11 - BIOS EQUITY PARTNERS III, LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 3.68M shares of Rein Therapeutics, Inc. Common Stock, $0.001 par value (RNTX).
This represents 6.2% percent ownership of the company.